Literature DB >> 23102190

Hospitalization for congestive heart failure: United States, 2000-2010.

Margaret Jean Hall1, Shaleah Levant, Carol J DeFrances.   

Abstract

Congestive heart failure (CHF) is a serious medical condition in which the heart cannot pump enough blood to meet the body's needs. CHF is often caused by hypertension, diabetes, or coronary heart disease. It is estimated that 5.8 million people in the United States have CHF (1). CHF is one of the most common reasons those aged 65 and over are hospitalized (2). This report presents National Hospital Discharge Survey (NHDS) data from 2000 through 2010 on hospitalizations for CHF. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Year:  2012        PMID: 23102190

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  29 in total

Review 1.  Heart failure in very old adults.

Authors:  Daniel E Forman; Ali Ahmed; Jerome L Fleg
Journal:  Curr Heart Fail Rep       Date:  2013-12

2.  Impact of Pharmacy Student-Driven Postdischarge Telephone Calls on Heart Failure Hospital Readmission Rates: A Pilot Program.

Authors:  Roda Plakogiannis; Ana Mola; Shreya Sinha; Abraham Stefanidis; Hannah Oh; Stuart Katz
Journal:  Hosp Pharm       Date:  2018-04-18

Review 3.  Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.

Authors:  Rachel Raynes; Laura C D Pomatto; Kelvin J A Davies
Journal:  Mol Aspects Med       Date:  2016-05-04

4.  The impact of age on the epidemiology of atrial fibrillation hospitalizations.

Authors:  Sahar Naderi; Yun Wang; Amy L Miller; Fátima Rodriguez; Mina K Chung; Martha J Radford; Joanne M Foody
Journal:  Am J Med       Date:  2013-10-16       Impact factor: 4.965

Review 5.  Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.

Authors:  Muthiah Vaduganathan; Javed Butler; Lothar Roessig; Gregg C Fonarow; Stephen J Greene; Marco Metra; Gadi Cotter; Stuart Kupfer; Andrew Zalewski; Naoki Sato; Gerasimos Filippatos; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

6.  Health Literacy and Outcomes in Patients With Heart Failure: A Prospective Community Study.

Authors:  Matteo Fabbri; Kathleen Yost; Lila J Finney Rutten; Sheila M Manemann; Cynthia M Boyd; Daniel Jensen; Susan A Weston; Ruoxiang Jiang; Véronique L Roger
Journal:  Mayo Clin Proc       Date:  2017-12-06       Impact factor: 7.616

7.  Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients with Heart Failure.

Authors:  Loretta Fala
Journal:  Am Health Drug Benefits       Date:  2016-03

Review 8.  Genetics of common forms of heart failure: challenges and potential solutions.

Authors:  Christoph D Rau; Aldons J Lusis; Yibin Wang
Journal:  Curr Opin Cardiol       Date:  2015-05       Impact factor: 2.161

Review 9.  Interventions for heart failure readmissions: successes and failures.

Authors:  Lisa M Fleming; Robb D Kociol
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 10.  The clinical anatomy and pathology of the human atrioventricular valves: implications for repair or replacement.

Authors:  Michael G Bateman; Jason L Quill; Alexander J Hill; Paul A Iaizzo
Journal:  J Cardiovasc Transl Res       Date:  2013-01-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.